Stocktoria

PolyPid Ltd. PYPD

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-06-26

PolyPid Ltd. statistics & valuation

P / B8.3×
Return on capital-226.3%
Graham number +10%$5.32

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($5.32); a green figure means the price is below it.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-50.70% -118.50% -678.60% -377.70% -311.40% 2019202020212022202320242025
Shares outstanding
562748 18.5M 18.8M 19.9M 1.7M 10.2M 18.2M 2019202020212022202320242025
Net debt ($)
$1.1M -$15.0M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-20.50% -48.60% -96.30% -152.30% -155.20% -115.10% -153.20% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
0.08× 2019202020212022202320242025
EPS ($)
$23.69 $4.48 $68.27 $61.09 $16.93 $4.91 $2.09 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

PolyPid Ltd. trades at about 2.3× earnings — above its 10-year norm (10-year range 0.4×–62.9×, median 2×).

0.4× 62.9×

Shaded band = 10-year range (0.4×–62.9×); dot = today's 2.3×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-153.2%-115.1%-155.2%-152.3%-96.3%-48.6%-20.5%
Return on equity-311.4%-377.7%1138.6%-678.6%-118.5%-50.7%7.9%
Debt / equity0.08×-3.04×
Current ratio1.971.310.831.664.3116.4110.62

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.